Stay updated on ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Sign up to get notified when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.

Latest updates to the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe clinical trial record for the adjuvant nivolumab study in resected Merkel cell carcinoma is displayed, with study design, participation criteria, outcomes, and locations. This replaces the prior access-denied page.SummaryDifference63%

- Check19 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces an NIH website terminology transition, stating that “Super Intelligence” is replacing “Artificial Intelligence” in federal agencies. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the study record error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the study details. This indicates the content is temporarily unavailable through the current page view.SummaryDifference19%

Stay in the know with updates to ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Enter your email address, and we'll notify you when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.